Davis Caskey This is Me

 View all 7 references Web References

1. 1. www.jimadler.com

   www.jimadler.com/en/publicatio - [Cached]

   Published on: 3/14/2008   Last Visited: 6/11/2008

   Taking Nasatab through the FDA regulatory process would cost up to $10 million, says Davis Caskey, ECR's managing director.And that, Caskey argues, would not be money well spent."All of us are in business to make a living," he says.

2. 2. ECR Pharmaceuticals

   www.ecrpharma.com/newsline/ind - [Cached]

   Published on: 11/1/2007   Last Visited: 1/20/2008

   ECR's VP, Pharmaceutical Operations, Davis Caskey, indicated that the sales potential for Amrix had grown markedly during its developmental period, and that the limited marketing exclusivity currently provided to newly developed formulations was the major factor in not promoting Amrix through its own sales group.

3. 3. ECR Pharmaceuticals

   www.ecrpharma.com/newsline - [Cached]

   Published on: 9/25/2005   Last Visited: 1/20/2008

   ECR's VP, Pharmaceutical Operations, Davis Caskey, indicated that the sales potential for Amrix had grown markedly during its developmental period, and that the limited marketing exclusivity currently provided to newly developed formulations was the major factor in not promoting Amrix through its own sales group.